These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15950642)

  • 21. Polymorphic Cytosine-Adenine-Guanine Repeat Length of Androgen Receptor Gene and Gender Incongruence in Trans Women: A Systematic Review and Meta-Analysis of Case-Control Studies.
    D'Andrea S; Pallotti F; Senofonte G; Castellini C; Paoli D; Lombardo F; Lenzi A; Francavilla S; Francavilla F; Barbonetti A
    J Sex Med; 2020 Mar; 17(3):543-550. PubMed ID: 31926901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of androgen receptor CAG repeat polymorphism in androgen excess disorder and idiopathic hirsutism.
    Polat S; Karaburgu S; Unluhizarci K; Dündar M; Özkul Y; Arslan YK; Karaca Z; Kelestimur F
    J Endocrinol Invest; 2020 Sep; 43(9):1271-1281. PubMed ID: 32166698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of CAG repeat length in the androgen-receptor gene using frozen serum.
    Sartor O; Zheng Q
    Urology; 1997 Feb; 49(2):301-4. PubMed ID: 9037303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Length of androgen receptor-CAG repeats in fertile and infertile Egyptian men.
    Badran WA; Fahmy I; Abdel-Megid WM; Elder K; Mansour R; Kent-First M
    J Androl; 2009; 30(4):416-25. PubMed ID: 19168451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome.
    Jones MR; Italiano L; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG
    Fertil Steril; 2006 Nov; 86(5):1438-46. PubMed ID: 17070195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CAG repeat polymorphism in the androgen receptor: a study on the effect of different numbers of repeats using Gene Ontology technique.
    Wiwanitkit V
    Fertil Steril; 2009 Jan; 91(1):e5-6. PubMed ID: 18222439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
    Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T
    Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anatomical evidence for in utero androgen exposure in women with polycystic ovary syndrome.
    Cattrall FR; Vollenhoven BJ; Weston GC
    Fertil Steril; 2005 Dec; 84(6):1689-92. PubMed ID: 16359966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome.
    Wang K; You L; Shi Y; Wang L; Zhang M; Chen ZJ
    Fertil Steril; 2008 Aug; 90(2):378-84. PubMed ID: 17953957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome.
    Walch K; Grimm C; Zeillinger R; Huber JC; Nagele F; Hefler LA
    Fertil Steril; 2004 Jun; 81(6):1638-41. PubMed ID: 15193488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines.
    Liede A; Zhang W; De Leon Matsuda ML; Tan A; Narod SA
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):848-52. PubMed ID: 14504193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor cytosine, adenine, and guanine trinucleotide repeat polymorphism in Korean patients with endometriosis: A case-control study.
    Shin JJ; Choi YM; Choi HY; Chae SJ; Hwang K; Kim JJ; Lee GH; Kim JM
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():1-4. PubMed ID: 28915409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.
    Xita N; Lazaros L; Georgiou I; Tsatsoulis A
    Fertil Steril; 2010 Jun; 94(1):250-4. PubMed ID: 19324338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between androgen receptor gene CAG trinucleotide repeat length and testicular histology in older men.
    Dakouane-Giudicelli M; Legrand B; Bergere M; Giudicelli Y; Cussenot O; Selva J
    Fertil Steril; 2006 Oct; 86(4):873-7. PubMed ID: 17027356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
    Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
    Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome.
    Shah NA; Antoine HJ; Pall M; Taylor KD; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2008 May; 93(5):1939-45. PubMed ID: 18303071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
    Esinler I; Bayar U; Bozdag G; Yarali H
    Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of short CAG and GGN repeats in the androgen receptor gene is associated with acne risk in North East China.
    Pang Y; He CD; Liu Y; Wang KB; Xiao T; Wang YK; Zhu H; Wei B; Zhao N; Jiang Y; Wei HC; Chen HD
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1445-51. PubMed ID: 18624843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between the androgen receptor CAG repeat polymorphism length and the response to intermittent androgen suppression therapy for advanced prostate cancer.
    Klotz L; Correia A; Zhang W
    Prostate Cancer Prostatic Dis; 2005; 8(2):179-83. PubMed ID: 15809670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.